Vietnam imported pharmaceutical products to the tune of US$449 million in December, up from US$284 million in November, a change of 58.35 percent, according to preliminary data from Vietnam’s General Department of Customs.
Year to date, Vietnam had imported US$4,296 million worth of pharmaceutical products by the end of December.
Ireland accounted for US$46 million worth of Vietnam’s pharmaceutical products imports in December. This was up from US$16 million in pharmaceutical products imports in November, a change of 191.52 percent. Year to date, Ireland has shipped US$225 million worth of pharmaceutical products to Vietnam.
After Ireland was India making up US$42 million worth of Vietnam’s pharmaceutical products imports in December. This was up from US$18 million in pharmaceutical products imports in November, a change of 132.38 percent. Year to date, India has shipped US$305 million worth of pharmaceutical products to Vietnam.
Next was France contributing US$37 million worth of Vietnam’s pharmaceutical products imports in December. This was up from US$31 million in pharmaceutical products imports in November, a change of 17.91 percent. Year to date, France has shipped US$486 million worth of pharmaceutical products to Vietnam.
Following France was Germany representing US$33 million worth of Vietnam’s pharmaceutical products imports in December. This was up from US$24 million in pharmaceutical products imports in November, a change of 39.28 percent. Year to date, Germany has shipped US$401 million worth of pharmaceutical products to Vietnam.
Rounding out the top five was the USA constituting US$30 million worth of Vietnam’s pharmaceutical products imports in December. This was down from US$39 million in pharmaceutical products imports in November, a change of 23.34 percent. Year to date, the USA has shipped US$515 million worth of pharmaceutical products to Vietnam.
Learn more about accessing Vietnam’s consumer market→
Vietnam imports of pharmaceutical products in December, US$m
| December | November | MoM | YTD | |
| Total | 449.18 | 283.66 | 58.35% | 4,295.73 |
| Other | 154.82 | 90.83 | 70.46% | 1,334.28 |
| Ireland | 45.57 | 15.63 | 191.52% | 224.88 |
| India | 41.76 | 17.97 | 132.38% | 305.07 |
| France | 36.76 | 31.18 | 17.91% | 486.17 |
| Germany | 33.13 | 23.79 | 39.28% | 400.75 |
| USA | 29.84 | 38.93 | -23.34% | 514.88 |
| South Korea | 28.25 | 15.37 | 83.77% | 157.22 |
| Italy | 25.03 | 31.36 | -20.18% | 307.27 |
| Belgium | 24.22 | 4.65 | 420.32% | 281.20 |
| Sweden | 15.14 | 3.46 | 337.38% | 156.70 |
| Spain | 14.66 | 10.48 | 39.84% | 127.30 |
| Switzerland | 12.39 | 2.91 | 326.20% | 120.61 |
| UK | 12.15 | 7.17 | 69.51% | 94.66 |
| Thailand | 10.40 | 6.62 | 57.04% | 76.03 |
| Netherlands | 8.50 | 5.86 | 45.18% | 91.48 |
| Austria | 8.10 | 8.76 | -7.50% | 102.28 |
| China | 7.75 | 6.97 | 11.20% | 63.10 |
| Japan | 7.53 | 4.39 | 71.45% | 62.34 |
| Hungary | 6.95 | 2.48 | 180.47% | 43.50 |
| Poland | 6.77 | 2.32 | 191.25% | 47.33 |
| Russia | 5.62 | 0.71 | 686.39% | 44.95 |
| Argentina | 5.38 | 0.07 | 7951.69% | 10.56 |
| Turkey | 4.61 | 1.10 | 319.50% | 25.63 |
| Cyprus | 4.23 | 1.88 | 125.06% | 27.10 |
| Denmark | 3.28 | 1.61 | 103.45% | 28.61 |
| Taiwan | 2.98 | 1.80 | 66.02% | 25.41 |
| Australia | 2.88 | 2.73 | 5.68% | 47.58 |
| Malaysia | 2.23 | 0.84 | 165.66% | 12.46 |
| Indonesia | 1.68 | 1.43 | 17.90% | 19.42 |
| Singapore | 1.52 | 1.19 | 27.13% | 15.62 |
| Bangladesh | 1.45 | 0.18 | 716.77% | 10.17 |
| Lithuania | 1.33 | 0.88 | 51.33% | 6.21 |
| Canada | 0.53 | 0.53 | 0.04% | 15.42 |
| Pakistan | 0.53 | 1.35 | -60.96% | 8.73 |
| Philippines | 0.11 | 0.10 | 3.69% | 0.74 |
Listed pharmaceutical products companies
Key pharmaceutical products firms listed on the Vietnam stock exchange include:
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD)
DBD closed at VND 51,600 on Tuesday down 0 percent with 576,000 shares traded, worth VND 2,960 million.
Foreign ownership in DBD is currently capped at 100.0 percent, with current foreign ownership sitting at 15.1 percent.
Ben Tre Pharmaceutical JSC
Ben Tre Pharmaceutical JSC (DBT) produces and distributes generic drugs, supplements, and medical products across Vietnam.
DBT closed at VND 11,000 on Tuesday down 0 percent with 1,000 shares traded, worth VND 1 million.
Foreign ownership in DBT is currently capped at 0.0 percent, with current foreign ownership sitting at 0.0 percent.
Cuu Long Pharmaceutical Joint Stock Corporation
Cuu Long Pharmaceutical Joint Stock Corporation (DCL) manufactures and distributes pharmaceutical and healthcare products under the Traphaco Group.
DCL closed at VND 55,000 on Tuesday up 0.4 percent with 5,114,000 shares traded, worth VND 27,936 million.
Foreign ownership in DCL is currently capped at 0.0 percent, with current foreign ownership sitting at 0.0 percent.
DHG Pharmaceutical Joint Stock Company
DHG Pharmaceutical Joint Stock Company (DHG) manufactures, markets, and distributes branded generic drugs and healthcare products nationwide.
DHG closed at VND 103,400 on Tuesday up 0.5 percent with 90,000 shares traded, worth VND 927 million.
Foreign ownership in DHG is currently capped at 100.0 percent, with current foreign ownership sitting at 54.0 percent.
Domesco Medical Import Export JSC
Domesco Medical Import Export JSC (DMC) manufactures and distributes pharmaceuticals, supplements, and medical equipment in Vietnam.
DMC closed at VND 60,900 on Tuesday down 0.1 percent with 1,000 shares traded, worth VND 6 million.
Foreign ownership in DMC is currently capped at 100.0 percent, with current foreign ownership sitting at 56.7 percent.
FIT Group JSC
FIT Group JSC (FIT) operates as a diversified holding company investing in pharmaceuticals, beverages, and consumer goods.
FIT closed at VND 4,780 on Tuesday down 0.04 percent with 8,305,000 shares traded, worth VND 3,959 million.
Foreign ownership in FIT is currently capped at 0.0 percent, with current foreign ownership sitting at 0.0 percent.
Imexpharm Corporation
Imexpharm Corporation (IMP) manufactures and distributes pharmaceuticals and healthcare products nationwide.
IMP closed at VND 53,700 on Tuesday down 0.2 percent with 232,000 shares traded, worth VND 1,244 million.
Foreign ownership in IMP is currently capped at 78.0 percent, with current foreign ownership sitting at 51.1 percent.
Explore opening a trading account in Vietnam→
Vietnam pharmaceutical products news
Recent developments include:
M&A China/VN pharmaceuticals
LIAN SGP Holding Pte. Ltd, a subsidiary of Livzon Pharmaceutical Group of China, has launched a public tender to acquire Imexpharm Joint Stock Company.
LIAN SGP is seeks=ing 120,059,970 shares, equal to 77.94 percent, at 57,400 Vietnamese dong per share, about US$2.18, valuing the deal at 6,891 billion Vietnamese dong, about US$261.6 million.
South Korea medical container factory
HuM&C, a healthcare materials subsidiary of Huons Group, has launched its first overseas medical container factory in Hung Yen Province, Vietnam, with full-scale production starting in the second quarter of 2025.
The Vietnam facility, operated by HuM&C Vina, can produce 60 million vials and 40 million cartridges annually, positioning it as a global production hub.
See the latest Vietnam news headlines→
Vietnam’s pharmaceutical products industry
Vietnam’s pharmaceutical products industry is expanding steadily, driven by population growth, rising incomes, and increased demand for modern healthcare and medicines.
The sector remains heavily dependent on imported active pharmaceutical ingredients and finished drugs, while local manufacturers focus mainly on generics and basic formulations for the domestic market.